Michael L Landrum
Overview
Explore the profile of Michael L Landrum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
1074
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Landrum M, Lalani T, Niknian M, Maguire J, Hospenthal D, Fattom A, et al.
Hum Vaccin Immunother
. 2016 Dec;
13(4):791-801.
PMID: 28010246
We conducted a randomized, double-blind, placebo-controlled dose-escalation study in healthy adults to evaluate the safety and immunogenicity of recombinant Staphylococcus aureus candidate vaccine antigens, recombinant α-toxoid (rAT) and a sub-unit...
2.
Burgess T, Murray C, Bavaro M, Landrum M, OBryan T, Rosas J, et al.
Vaccine
. 2015 Jun;
33(32):3894-9.
PMID: 26117150
Background: In outbreak settings, mass vaccination strategies could maximize health protection of military personnel. Self-administration of live attenuated influenza vaccine (LAIV) may be a means to vaccinate large numbers of...
3.
Okulicz J, Le T, Agan B, Camargo J, Landrum M, Wright E, et al.
JAMA Intern Med
. 2014 Nov;
175(1):88-99.
PMID: 25419650
Importance: In individuals with human immunodeficiency virus 1 (HIV-1) infection who are receiving antiretroviral therapy (ART), factors that promote full immune recovery are not well characterized. Objective: To investigate the...
4.
Patterson S, Landrum M, Okulicz J
Vaccine
. 2014 May;
32(27):3341-4.
PMID: 24793945
Background: Delayed-type hypersensitivity (DTH) test responsiveness is associated with HIV disease progression; however it is unknown whether other immune markers, such as hepatitis B virus (HBV) vaccine seroresponse, also predict...
5.
Chun H, Mesner O, Thio C, Bebu I, Macalino G, Agan B, et al.
J Acquir Immune Defic Syndr
. 2014 Apr;
66(2):197-205.
PMID: 24694929
Background: Understanding the impact of hepatitis B virus (HBV) coinfection on HIV outcomes in the highly active antiretroviral therapy (HAART) era continues to be a critical priority given the high...
6.
Johnson E, Roediger M, Landrum M, Crum-Cianflone N, Weintrob A, Ganesan A, et al.
AIDS Res Ther
. 2014 Jan;
11(1):10.
PMID: 24460764
Background: Prior studies have suggested that HAART initiation may vary by race/ethnicity. Utilizing the U.S. military healthcare system, which minimizes confounding from healthcare access, we analyzed whether timing of HAART...
7.
Vento T, Calvano T, Cole D, Mende K, Rini E, Tully C, et al.
BMC Infect Dis
. 2013 Sep;
13:325.
PMID: 24060181
Background: Staphylococcus aureus [methicillin-resistant and methicillin-susceptible (MRSA/MSSA)] is a leading cause of infections in military personnel, but there are limited data regarding baseline colonization of individuals while deployed. We conducted...
8.
Shaw A, Vento T, Mende K, Kreft R, Ehrlich G, Wenke J, et al.
Scand J Infect Dis
. 2013 Aug;
45(10):752-9.
PMID: 23957540
Background: Methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) Staphylococcus aureus colonization is associated with increased rates of infection. Rapid and reliable detection methods are needed to identify colonization of nares and extra-nare...
9.
Chun H, Thio C, Agan B, Landrum M
J Infect Dis
. 2013 Jul;
208(7):1186.
PMID: 23840048
No abstract available.
10.
Vento T, Cole D, Mende K, Calvano T, Rini E, Tully C, et al.
BMC Infect Dis
. 2013 Feb;
13:68.
PMID: 23384348
Background: The US military has seen steady increases in multidrug-resistant (MDR) gram-negative bacteria (GNB) infections in casualties from Iraq and Afghanistan. This study evaluates the prevalence of MDR GNB colonization...